Yale School of Medicine researchers published a report this month in the Archives of General Psychiatry that highlights the interplay of two brain signaling systems, glutamate and dopamine, in psychosis and cognitive function.

Science once again shows that a single answer for a complex problem is most likely incomplete, and that many factors can be in play when trying to diagnose conditions as varied as psychosis and schizophrenia.